发明名称 SERUM FRACTION OF PLATELET-RICH FIBRIN
摘要 The invention provides for a method of preparing an isolated serum fraction of platelet rich fibrin (PRF), comprising the steps of a. providing platelet rich plasma (PRP) without the addition of an anticoagulant;b. clotting the PRP to obtain a coagel of PRF; andc. separating the coagel to isolate the serum fraction which comprises an activated platelet releasate;and further provides for the isolated serum fraction obtained by such method, and its medical use.
申请公布号 US2017035809(A1) 申请公布日期 2017.02.09
申请号 US201615283576 申请日期 2016.10.03
申请人 Lacerta Technologies Inc. 发明人 LACZA Zsombor;VÁCZ Gabriella
分类号 A61K35/19 主分类号 A61K35/19
代理机构 代理人
主权项 1. A pharmaceutical preparation comprising a blood-derived serum product which is an isolated serum fraction of platelet rich fibrin (PRF) said a blood-derived serum product being contained in an application device for administration of the serum fraction to an individual and being obtained by a method comprising the steps of a. separating and removing the red blood cell fraction from a venous blood sample without the addition of an anticoagulant to provide a plasma having a platelet concentration above baseline; b. clotting said plasma to obtain a coagel of PRF spontaneously by centrifugation carried out at 1000 to 5000 g; c. pressing or squeezing the coagel to separate a serum fraction which comprises an activated platelet releasate from the coagel, thereby obtaining an isolated serum fraction containing the fluid fraction of PRF; and d. providing the serum fraction in a pharmaceutical preparation which is contained in an application device for administration of the serum fraction to an individual, said serum fraction comprising a platelet releasate from activated platelets.
地址 Raleigh NC US